Indication

B. fragilis infection

A *B. Read more about B. fragilis infection

56 drugs 52 manufacturers

Advertisement

Drugs that treat it

Common B. fragilis infection therapies.

Showing 1–9 of 56 drugs

METRONIDAZOLE

ACUTE INTESTINAL AMEBIASIS DUE TO ENTAMOEBA HISTOLYTICA·+54
APACE PACKAGING

METRONIDAZOLE

NITROIMIDAZOLE ANTIBIOTICS·ACUTE INTESTINAL AMEBIASIS DUE TO ENTAMOEBA HISTOLYTICA·+54
Major Pharamceuticals

METRONIDAZOLE

ACUTE INTESTINAL AMEBIASIS DUE TO ENTAMOEBA HISTOLYTICA·+54
PLIVA, INC

METRONIDAZOLE

ACUTE INTESTINAL AMEBIASIS DUE TO ENTAMOEBA HISTOLYTICA·+54
MYLAN INSTITUTI
Filter & compare in the drug finder →Opens the drug finder with B. fragilis infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About B. fragilis infection.

A *B.

fragilis* infection is an opportunistic, often polymicrobial bacterial infection caused by *Bacteroides fragilis*, an obligate anaerobic, gram-negative bacillus that normally resides as a commensal organism within the human gastrointestinal tract.

Clinically significant infection arises when mucosal barriers are disrupted by abdominal trauma, gastrointestinal perforation, bowel ischemia, surgery, or underlying pelvic and intestinal disease, allowing the organism to invade normally sterile anatomical sites.

The condition predominantly manifests in adults and postoperative surgical patients as localized intra-abdominal or pelvic abscesses, peritonitis, complicated skin and soft tissue infections, or life-threatening bacteremia.

Pathophysiologically, the organism's distinctive capsular polysaccharide complex drives purulent inflammation and potent intra-abdominal abscess formation while protecting the bacteria from host phagocytosis and complement-mediated killing.

Personalize your experience

Follow B. fragilis infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it